Portland Veterans Administration Medical Center — Portland, Oregon

Portland Veterans Administration Medical Center is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Portland Veterans Administration Medical Center has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Head and Neck Cancer, MRI, Prostate Cancer.

Sponsors: Radiation Therapy Oncology Group, Oregon Health and Science University, SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Portland Veterans Administration Medical Center?

Portland Veterans Administration Medical Center has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Portland Veterans Administration Medical Center conducted?

Portland Veterans Administration Medical Center has 6 clinical trials on record, with 3 currently active. Their work covers Head and Neck Cancer, MRI, Prostate Cancer.

Is Portland Veterans Administration Medical Center accredited by Crixeo Clinical Trials?

Portland Veterans Administration Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Portland Veterans Administration Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.